BUZZ — Australia's CurveBeam rises on Chinese approval of medical imaging device

* Shares of Australia's CurveBeam AI rise as much as 35% to A$0.027, their biggest intraday pct gain since September 16 * Stock hits its highest level since September 24 * Medical equipment maker says its HiRise weight-bearing specialised medical imaging has received approval from China's National Medical Products Administration * Stock down over 60% this year, including the day's move (Reporting by Rajasik Mukherjee in Bengaluru) ((mailto:Rajasik.Mukherjee@thomsonreuters.com)